Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome
AssigneeUniversity of Utah Research Foundation
InventorsJulie Ruth Korenberg, Karen Sue Wilcox, Peter Jeffrey West, Raymond Pierre Kesner
Life of this patent
Estimating the term…
Abstract
Methods for treating Down syndrome and improving cognitive function of a patient with an intellectual disability are disclosed. 5-hydroxytryptamine sub-receptor six (5-HT6) receptor antagonists are provided for improving the cognition of a Down syndrome patient.
Claims22
A method of treating Down syndrome, comprising administering to a subject in need thereof an effective amount of a 5-HT6 receptor antagonist.
A method of improving cognitive function of a human child suffering from an intellectual disability, the method comprising administering an effective amount of a 5-HT6 receptor antagonist.
A kit for use in improving the cognitive function of a subject suffering from Down syndrome, said kit comprising:
- a 5-HT6 receptor antagonist provided in a pharmaceutically acceptable formulation;
- and
- instructions for treating Down syndrome.
Dependencies are inferred from the claim text.